Bengaluru Startup Uses Trained Dogs and AI to Detect Cancer from Breath Samples
A Bengaluru startup, Dognosis Biosciences, has developed a method combining trained dogs and artificial intelligence to detect multiple types of cancer from human breath samples with over 90% accuracy, including early-stage cases. Their study, involving 3,275 participants across six Karnataka hospitals, was published in the Journal of Clinical Oncology. The approach uses dogs' olfactory abilities alongside AI analysis, with ongoing training to improve reliability despite challenges posed by biological variability.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. Coverage leans balanced overall (Left 0%, Centre 100%, Right 0%). Overall sentiment is positive (75/100). Lens Score 31/100 — low public interest.
Outlets analysed (first-hand measurement by TBN's Bias Engine):
- hindustantimes— balanced framing, positive sentiment
- wion— balanced framing, positive sentiment
AI Analysis
The articles present a technology-focused narrative without evident political framing. They emphasize scientific innovation and healthcare advancement, highlighting a startup's research and development efforts. Perspectives include the startup's founders and researchers, with no partisan viewpoints or political commentary, maintaining a neutral stance centered on medical and technological progress.
The overall tone is cautiously optimistic, emphasizing promising scientific results and innovative methods. While acknowledging challenges in adopting unorthodox testing involving animals, the coverage highlights the potential benefits of early cancer detection. The sentiment is positive toward the technology's capabilities, balanced by recognition of the need for further validation and acceptance.
How 2 sources covered this story
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.
